BUXOCURE 80
TM Tablets contain Febuxostat in a higher strength, providing enhanced reduction of serum uric acid levels in patients with gout. It works by inhibiting xanthine oxidase, thereby decreasing uric acid production. This formulation is commonly used in patients who require stronger uric acid control or who do not achieve adequate response with lower doses.
Composition
Key Features & Benefits
- Higher Strength Efficacy: Provides stronger uric acid lowering effect
- Gout Prevention: Helps reduce frequency of gout flares
- Targeted Mechanism: Selectively inhibits xanthine oxidase
- Suitable for Chronic Therapy: Ideal for long-term management
- Clinically Trusted: Widely used in gout treatment
Recommended Usage
- To be taken as prescribed by a healthcare professional
- Can be taken with or without food
- Follow the prescribed dosage and duration strictly
Safety Information
- Not recommended in patients with hypersensitivity to Febuxostat
- Use cautiously in patients with cardiovascular or liver conditions
- Monitor uric acid levels periodically
- Do not discontinue therapy without medical advice
Storage Instructions
- Store in a cool, dry place
- Protect from moisture and direct sunlight
- Keep out of reach of children
